“禁豆”谣言从何而起？ ❌豆制品属于“植物蛋白”，是劣质蛋白？ 大豆蛋白是植物界中唯一的“完全蛋白”，必需氨基酸齐全，蛋白质量可以媲美肉蛋奶。 ❌肾病要限制蛋白质，不能吃豆制品？ 肾病限制的是全天蛋白质总数量，不是专门禁止豆制品，用豆制品替换部分肉类 ...

Most foamy urine is nothing to worry about but not all of it A urologist explains when its harmless when its not and what ...

The "Focal Segmental Glomerulosclerosis - Market Insight, Epidemiology, Forecast - 2036" has been added to ResearchAndMarkets.com's offering. The report provides an in-depth assessment of FSGS ...

The patient's phenotype, rather than the variant of uncertain significance, supported withholding immunosuppression and using supportive therapy.

Finerenone has shown positive therapeutic effects in diabetic kidney disease, but its role in hereditary podocytopathies such as hereditary FSGS has not been fully explored.

The FDA’s Office of Prescription Drug Promotion sent Travere Therapeutics a letter over its advertising for Filspari, a drug that’s approved to slow kidney function decline in people with primary IgA ...

In July, Korea approved a new treatment regimen combining the immune checkpoint inhibitor pembrolizumab (sold as Keytruda) ...

Alebund Pharmaceuticals has received FDA IND clearance for AP308, a first-in-class engineered IgA protease designed to ...

US FDA clears Alebund Pharmaceuticals’ IND application for AP308 for the treatment of IgA nephropathy: Shanghai, China Thursday, September 10, 2026, 13:00 Hrs [IST] Alebund Phar ...

Alebund Pharmaceuticals (09637.HK) announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for AP308, an investigational engineered ...

Rituximab is associatied with numerically higher remission rates in lupus membranous nephritis, although 12-month renal response rates did not differ significantly across immunosuppressive strategies.

SHANGHAI, Sept. 8, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that it has ...